z-logo
open-access-imgOpen Access
Pharmacy Students' Knowledge of Black Box Warnings
Author(s) -
Karen E. Moeller,
Theresa I. Shireman,
Joyce A. Generali,
Sally K. Rigler,
Angela Mayorga
Publication year - 2010
Publication title -
american journal of pharmaceutical education
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.796
H-Index - 63
eISSN - 1553-6467
pISSN - 0002-9459
DOI - 10.5688/aj740105
Subject(s) - pharmacy , medical education , black box , medicine , psychology , family medicine , computer science , artificial intelligence
Objective. To evaluate the progression of pharmacy students’ knowledge of black box warnings across 3 years of didactic training, and to determine how they stay current with new warnings. Methods. A cross-sectional survey instrument was administered to pharmacy students in their first (P1), second (P2), and third (P3) professional years. The survey assessed student awareness of medications possessing a black box warning and familiarity with the warning content for 20 medications (15 with and 5 without warnings). Results. Mean number of correct responses identifying the presence or absence of a black box warning among the 20 medications were 5.8 ± 3.3, 9.6 ± 4.0, and 14.8 ± 2.8 for the P1, P2, and P3 students, respectively. Knowledge of black box warning content was variable. Students were least aware of the warning content for stavudine and enoxaparin. Students were most familiar with the warning content for paroxetine and estrogen. Conclusion. Students' awareness and understanding of black box warnings was proportional to their educational progression, but their knowledge level was inconsistent across drug groups.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom